These data, together with our findings in HCC cells and mouse xenograft model, suggest that downregulation of FBXO7 in human HCC is a major mechanism contributing to PRMT1-mediated elevation of PHGDH R236 mono-methylation and activity in HCC. This evidence concerns the gene FBXO7 and hepatocellular carcinoma.